Search results - ORA - Oxford University Research Archive

1 - 9 of 9

1

Journal article

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Griffin, SJ, Bethel, MA, Holman, RR, et al.
2018-04-30

2

Journal article

Economic evaluation of factorial trials: cost-utility analysis of the AFORRD 2x2x2 factorial trial of atorvastatin, omega-3 fish oil and action-planning

Dakin, HA, Farmer, A, Gray, AM, et al.
2020-08-18

3

Journal article

Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure

Hundertmark, MJ, Agbaje, OF, Coleman, R, et al.
2021-05-06

4

Journal article

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial

Becker, F, Dakin, HA, Reed, SD, et al.
2021-11-20

5

Conference item

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Conference abstract
Xu, S, Scott, C, Coleman, RL, et al.
2019-08-05

6

Journal article

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)

Leal, J, Alva, M, Gregory, V, et al.
2021-07-23

7

Conference item

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model

Conference abstract
Coleman, RL, Gray, AM, McGuire, DK, et al.
2019-08-05

8

Journal article

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA‐REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?

Coleman, RL, Gray, AM, Broedl, UC, et al.
2020-03-20

9

Journal article

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease

Mostafa, SA, Coleman, RL, Agbaje, OF, et al.
2017-11-16

TO TOP